Free fatty acids and insulin resistance

被引:370
作者
Delarue, Jacques [1 ]
Magnan, Christophe
机构
[1] CHU Cavale Blanche, Lab Reg Nutr Humaine, F-29200 Brest, France
[2] CHU Cavale Blanche, EA 948, F-29200 Brest, France
[3] Univ Bretagne Occidentale, Brest, France
[4] Univ Paris, F-75252 Paris, France
关键词
acyl-CoA; ceramide; peroxisome; proliferator-activated receptor; serine/threonine kinase; MAGNETIC-RESONANCE-SPECTROSCOPY; HUMAN SKELETAL-MUSCLE; HUMAN ADIPOSE-TISSUE; WEIGHT-LOSS; METABOLIC SYNDROME; GLUCOSE-PRODUCTION; HUMAN OBESITY; IN-VIVO; HUMANS; MECHANISMS;
D O I
10.1097/MCO.0b013e328042ba90
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review Dysregulation of free fatty acid metabolism is a key event responsible for insulin resistance and type 2 diabetes. According to the glucose-fatty acid cycle of Randle, preferential oxidation of free fatty acids over glucose plays a major role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. However, other mechanisms are now described to explain the molecular basis of insulin resistance., Recent findings Recent studies have suggested that local accumulation of fat metabolites such as ceramides, diacylglycerol or acyl-CoA, inside skeletal muscle and liver, may activate a serine kinase cascade leading to defects in insulin signalling and glucose transport. Inflammation and oxidative stress are also potent mechanisms which could lead to a state of insulin resistance. Finally, modulation of transcription by free fatty acids through their binding to peroxisome proliferator-activated receptors could also contribute to impaired glucose metabolism. Summary The increase in free fatty acid flux resulting from increased lipolysis secondary to adipose-tissue. insulin resistance induces or aggravates insulin resistance in liver and muscle through direct or indirect (from triglyceride deposits) generation of metabolites, altering the insulin signalling pathway. Alleviating the excess of free fatty acids is a target for the treatment of insulin resistance.
引用
收藏
页码:142 / 148
页数:7
相关论文
共 50 条
[1]   Resistin: Can we resist its role in insulin resistance? [J].
Alzahrani, AS .
ANNALS OF SAUDI MEDICINE, 2005, 25 (04) :281-282
[2]   Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients [J].
Bajaj, M ;
Suraamornkul, S ;
Piper, P ;
Hardies, LJ ;
Glass, L ;
Cersosimo, E ;
Pratipanawatr, T ;
Miyazaki, Y ;
Defronzo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) :200-206
[3]   Systemic and regional free fatty acid metabolism in type 2 diabetes [J].
Basu, A ;
Basu, R ;
Shah, P ;
Vella, A ;
Rizza, RA ;
Jensen, MD .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 280 (06) :E1000-E1006
[4]  
Beltowski J, 2003, MED SCI MONITOR, V9, P55
[5]   Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance [J].
Blaak, EE .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 19 (03) :391-403
[6]   Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes [J].
Boden, G ;
Chen, XH ;
Capulong, E ;
Mozzoli, M .
DIABETES, 2001, 50 (04) :810-816
[7]   Interaction between free fatty acids and glucose metabolism [J].
Boden, G .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2002, 5 (05) :545-549
[8]   FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis [J].
Boden, G ;
Cheung, P ;
Stein, TP ;
Kresge, K ;
Mozzoli, M .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 283 (01) :E12-E19
[9]   Association of resistin with visceral fat and muscle insulin resistance [J].
Borst, SE ;
Conover, CF ;
Bagby, GJ .
CYTOKINE, 2005, 32 (01) :39-44
[10]   Fuel metabolism in starvation [J].
Cahill, George F., Jr. .
ANNUAL REVIEW OF NUTRITION, 2006, 26 :1-22